UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000010739
Receipt number R000012544
Scientific Title Phase II trial of amrubicin treatment as palliative-intended chemotherapy for previously treated malignant pleural mesothelioma
Date of disclosure of the study information 2013/05/16
Last modified on 2019/03/22 11:32:27

No. Disposal Last modified on Item of update
1 Insert 2013/05/16 10:47:20
2 Update 2013/05/16 19:28:17 Date of disclosure of the study information
3 Update 2013/06/25 20:46:31 Recruitment status
Date of protocol fixation
4 Update 2014/03/08 13:05:35 Email
Email
5 Update 2016/04/01 15:11:02 Name of primary person or sponsor
Organization
6 Update 2016/04/07 23:33:06 Name of primary person or sponsor
Organization
7 Update 2016/04/07 23:40:40 Name of primary person or sponsor
Organization
8 Update 2016/11/17 18:25:28 Interventions/Control_1
Key inclusion criteria
9 Update 2018/05/20 10:02:47 Recruitment status
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2019/03/22 11:27:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
11 Update 2019/03/22 11:29:37 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2019/03/22 11:30:45 Number of participants that the trial has enrolled
13 Update 2019/03/22 11:32:27 Recruitment status
Date of IRB